News
Randomized sub-trial 1 of a global adaptive platform trial of COM701 maintenance therapy in patients with relapsed platinum sensitive ovarian cancer Trial supported by strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback